Genesis Therapeutics logo

Genesis Therapeutics

Healthcare & Life Sciences

Recent Finacing

Equity

Recent Raise

Undisclosed


Genesis Therapeutics uses AI technology to enhance drug discovery and develop therapies for diseases with high unmet needs.

Total Funding

$300M

Headquarters

Burlingame, USA

Founded

N/A

Focus Areas

AI platform
drug discovery
equivariant neural networks
computational methods
therapies development
chemical pathways

Investors

NVentures logo